Terriou et al. (15) evaluated CEBPA promoter methylation in 5 AML and 99 T-ALL cases, with expression of cytoplasmic CD3 and CD7 transcripts, T-cell receptor rearrangement, and NOTCH1 mutations. This evidence concerns the gene CD7 and acute lymphoblastic leukemia.